Long-term therapy of osteoarthritis of the hip and the knee by sulindac (a cooperative trial in general practice) (author's transl)

Long-term trial of sulindac (in general practice): 2,040 patients with osteoarthritis of the hip or of the knee been treated, 86,5% of them have been following the treatment for one year. This trial let us pointing out the non-improverishment of effectiveness of sulindac and the keepint of its good...

Full description

Saved in:
Bibliographic Details
Published inLa semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris Vol. 55; no. 7-8; p. 379
Main Authors Maestracci, D, Sarre, J
Format Journal Article
LanguageFrench
Published France 18.02.1979
Subjects
Adult
Age Factors
Aged
Drug Evaluation
Female
Follow-Up Studies
Hip Joint
Humans
Indenes - therapeutic use
Knee Joint
Male
Middle Aged
Osteoarthritis - drug therapy
Sex Factors
Sulindac - administration & dosage
Sulindac - adverse effects
Sulindac - therapeutic use
Time Factors
Online AccessGet more information

Cover

More Information
Summary:Long-term trial of sulindac (in general practice): 2,040 patients with osteoarthritis of the hip or of the knee been treated, 86,5% of them have been following the treatment for one year. This trial let us pointing out the non-improverishment of effectiveness of sulindac and the keepint of its good tolerance for long term. Some epidemiological data have been collected, among which: the importance of ponderal overload in patients studied and the prevalence of the right joints diseases on the left one's.